Neurovations

Neurovations is a private U.S. healthcare and clinical research company founded in 1992 by Dr. Eric Grigsby and headquartered in Napa, California. The organization combines patient care, independent clinical research, medical device and pharmaceutical innovation, laboratory services, and medical education, with a particular focus on pain management and neuroscience. Through Neurovations Research, the company conducts Phase I-IV clinical trials for medical devices, pharmaceuticals, and biologics, often serving as a site partner rather than a traditional drug-development sponsor. Its operating footprint also includes the Napa Pain Institute, N3 Laboratories, and educational activities under the Neurovations brand. Overall, Neurovations appears best characterized as an integrated healthcare and research enterprise in pain and neurologic disease rather than a classic venture-backed therapeutic biotech with a proprietary drug pipeline.